Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
暂无分享,去创建一个
B. Brundel | P. Ferdinandy | F. Asselbergs | M. Gyöngyösi | C. Tschöpe | S. Steffens | M. Gnecchi | F. Asselbergs | S. Davidson | R. Madonna | M. Fontana | A. Pantazis | C. Perrino | P. Alcaide | J. Sluijter | P. Kleinbongard | H. Girão | P. A. da Costa Martins | G. Camici | S. Van Linthout | G. Schiattarella | M. Paillard | S. Linthout | P. D. C. Martins | C. Gollmann-Tepeköylü | M. Pesce | T. Krieg | Maurizio Pesce
[1] Guohui Fan,et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2023, The Lancet.
[2] H. Hedlin,et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection , 2022, Med.
[3] N. Horita,et al. Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis , 2022, Heart and Vessels.
[4] Lisa E. Gralinski,et al. A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies , 2022, bioRxiv.
[5] S. Efrati,et al. Hyperbaric oxygen treatment for long coronavirus disease-19: a case report , 2022, Journal of Medical Case Reports.
[6] Benjamin Bowe,et al. Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.
[7] M. Hayıroğlu,et al. Heart rate variability and cardiac autonomic functions in post-COVID period , 2022, Journal of Interventional Cardiac Electrophysiology.
[8] B. Knechtle,et al. What should a family physician know about nutrition and physical exercise rehabilitation’ advices to communicate to ‘long-term COVID-19’ patients? , 2022, Postgraduate medicine.
[9] M. Puhan,et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome , 2022, Nature Communications.
[10] A. Slooter,et al. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. , 2022, JAMA.
[11] K. Stavem,et al. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID‐19 , 2022, Journal of the American Heart Association.
[12] Anchisa Kunawudhi,et al. Abnormality Pattern of F-18 FDG PET Whole Body with Functional MRI Brain in Post-Acute COVID-19 , 2022, Nuclear Medicine and Molecular Imaging.
[13] P. Duggal,et al. Post‐sequelae symptoms and comorbidities after COVID‐19 , 2022, Journal of medical virology.
[14] E. Çelik,et al. Evaluation of 3‐month follow‐up of patients with postacute COVID‐19 syndrome , 2022, Journal of medical virology.
[15] M. Aepfelbacher,et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme , 2022, European heart journal.
[16] A. Dror,et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021 , 2022, medRxiv.
[17] B. Merkely,et al. Frequent Constriction-Like Echocardiographic Findings in Elite Athletes Following Mild COVID-19: A Propensity Score-Matched Analysis , 2022, Frontiers in Cardiovascular Medicine.
[18] Inyoul Y. Lee,et al. Multiple early factors anticipate post-acute COVID-19 sequelae , 2022, Cell.
[19] J. Suri,et al. Long-COVID diagnosis: From diagnostic to advanced AI-driven models , 2022, European Journal of Radiology.
[20] C. Tudoran,et al. Evolution of Echocardiographic Abnormalities Identified in Previously Healthy Individuals Recovering from COVID-19 , 2022, Journal of personalized medicine.
[21] V. Chaturvedi,et al. Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence , 2022, Indian Pacing and Electrophysiology Journal.
[22] Deepak L. Bhatt,et al. Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes , 2021, Journal of the American Heart Association.
[23] Nelson B Rodrigues,et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis , 2021, Brain, Behavior, and Immunity.
[24] J. de Mey,et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19 , 2021, Diagnostics.
[25] K. Nadeau,et al. Association Between SARS-CoV-2 RNAemia and Postacute Sequelae of COVID-19 , 2021, Open forum infectious diseases.
[26] K. Klingel,et al. COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy , 2021, Frontiers in Cardiovascular Medicine.
[27] Vibha Jain,et al. Stacking Ensemble-Based Intelligent Machine Learning Model for Predicting Post-COVID-19 Complications , 2021, New Generation Computing.
[28] A. Ambrose,et al. Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC) , 2021, PM & R : the journal of injury, function, and rehabilitation.
[29] P. Heerdt,et al. Impaired systemic oxygen extraction long after mild COVID-19: potential perioperative implications , 2021, British Journal of Anaesthesia.
[30] Janet Diaz,et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.
[31] R. Guner,et al. Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19 , 2021 .
[32] P. Thompson,et al. Diagnosing COVID-19 myocarditis in athletes using cMRI , 2021, Trends in Cardiovascular Medicine.
[33] P. Ladlow,et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations , 2021, Heart Rhythm.
[34] L. Abid,et al. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study , 2021, Frontiers in Cardiovascular Medicine.
[35] K. Chamari,et al. General practitioners should provide the cardiorespiratory rehabilitation’ ‘minimum advice’ for long COVID-19 patients , 2021, The Libyan journal of medicine.
[36] S. Goland,et al. Subclinical Myocardial Dysfunction in Patients Recovered from COVID-19 Disease: Correlation with Exercise Capacity , 2021, Biology.
[37] M. Ståhlberg,et al. Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know? , 2021, Journal of cardiovascular development and disease.
[38] T. Robbins,et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. , 2021, Clinical medicine.
[39] N. Sverzellati,et al. Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles , 2021, Diagnostics.
[40] P. Tepasse,et al. Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis , 2021, Viruses.
[41] Deepak L. Bhatt,et al. Cardiac involvement in the long-term implications of COVID-19 , 2021, Nature Reviews Cardiology.
[42] C. von Kalle,et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP) , 2021, Infection.
[43] J. W. Wassenaar,et al. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC) , 2021, Journal of Cardiovascular Magnetic Resonance.
[44] H. Schultheiss,et al. Cardiovascular consequences of viral infections: from COVID to other viral diseases , 2021, Cardiovascular research.
[45] A. Lerman,et al. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19 , 2021, International Journal of Cardiology.
[46] P. Kearns,et al. The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery , 2021, iScience.
[47] E. Arbustini,et al. Long COVID: long-term effects? , 2021, European heart journal supplements : journal of the European Society of Cardiology.
[48] V. Bucciarelli,et al. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference , 2021, Trends in Cardiovascular Medicine.
[49] F. Hakim,et al. COVID-19 vaccine – Long term immune decline and breakthrough infections , 2021, Vaccine.
[50] J. Todd,et al. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus , 2021, Nature Genetics.
[51] D. Tousoulis,et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) , 2021, Cardiovascular research.
[52] R. Eils,et al. Virus-induced senescence is a driver and therapeutic target in COVID-19 , 2021, Nature.
[53] S. Solomon,et al. Recovery of cardiac function following COVID‐19 – ECHOVID‐19: a prospective longitudinal cohort study , 2021, European journal of heart failure.
[54] S. Yende,et al. Long COVID and kidney disease , 2021, Nature Reviews Nephrology.
[55] J. Geddes,et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 , 2021, PLoS medicine.
[56] Samin K. Sharma,et al. Types of myocardial injury and mid-term outcomes in patients with COVID-19. , 2021, European heart journal. Quality of care & clinical outcomes.
[57] A. Schmermund,et al. Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis , 2021, Clinical Research in Cardiology.
[58] C. Kropf-Sanchen,et al. Long COVID: Distinction between Organ Damage and Deconditioning , 2021, Journal of clinical medicine.
[59] I. Andreadou,et al. Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection , 2021, European journal of heart failure.
[60] Md Rezaul Karim,et al. Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients—A Prospective Multicenter Cross-Sectional Study , 2021, Frontiers in Medicine.
[61] S. Snyder,et al. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome , 2021, Proceedings of the National Academy of Sciences.
[62] P. Manganotti,et al. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study , 2021, Journal of Neurology.
[63] A. Faron,et al. Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19 , 2021, Radiology.
[64] T. Renné,et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome , 2021, Journal of Thrombosis and Haemostasis.
[65] S. Piechnik,et al. Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19 , 2021, EClinicalMedicine.
[66] T. Vos,et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19 , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[67] W. Niehaus,et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS‐CoV‐2 infection (PASC) patients , 2021, PM & R : the journal of injury, function, and rehabilitation.
[68] S. Wiethoff,et al. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19 , 2021, Journal of the Neurological Sciences.
[69] G. Pizarro,et al. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement , 2021, IJC Heart & Vasculature.
[70] S. Drakos,et al. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients , 2021, Scientific Reports.
[71] N. Schiefermeier-Mach,et al. Post-COVID-19 Rehabilitation: Perception and Experience of Austrian Physiotherapists and Physiotherapy Students , 2021, International journal of environmental research and public health.
[72] Suhua Zhou,et al. Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications? , 2021, Free Radical Biology and Medicine.
[73] M. Ünlü,et al. Laboratory and Imaging Evaluation of Cardiac Involvement in Patients with Post-Acute COVID-19 , 2021, International journal of general medicine.
[74] I. Pavord,et al. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients , 2021, Pragmatic and observational research.
[75] M. Maniscalco,et al. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study , 2021, Biomedicines.
[76] L. Schomburg. Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19—A Preventable Trigger for Autoimmune Disease , 2021, International journal of molecular sciences.
[77] P. Edison,et al. Long covid—mechanisms, risk factors, and management , 2021, BMJ.
[78] F. Dioguardi,et al. Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications , 2021, Frontiers in Medicine.
[79] K. Roe. A role for T‐cell exhaustion in Long COVID‐19 and severe outcomes for several categories of COVID‐19 patients , 2021, Journal of neuroscience research.
[80] A. Allegretti,et al. Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza , 2021, Kidney International Reports.
[81] Mattia G. Bergomi,et al. Mapping the human genetic architecture of COVID-19 , 2021, Nature.
[82] L. Walton,et al. Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors , 2021, BMJ Global Health.
[83] Chen-Yu Zhang,et al. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease , 2021, Cell discovery.
[84] D. Kobak,et al. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset , 2021, eLife.
[85] A. Lucendo,et al. Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge , 2021, Journal of clinical medicine.
[86] F. Koehler,et al. Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice , 2021, ESC heart failure.
[87] R. V. Vander Heide,et al. COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism , 2021, Cardiovascular Pathology.
[88] K. Meyer,et al. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells , 2021, Journal of virology.
[89] H. Bartsch,et al. Long COVID in a prospective cohort of home-isolated patients , 2021, Nature Medicine.
[90] A. Della Corte,et al. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review , 2021, Clinical Microbiology and Infection.
[91] P. Goepfert,et al. Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses , 2021, JCI insight.
[92] H. Bøtker,et al. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. , 2021, Cardiovascular research.
[93] N. LeBrasseur,et al. Senolytics reduce coronavirus-related mortality in old mice , 2021, Science.
[94] P. Richardson,et al. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? , 2021, Cardiovascular Drugs and Therapy.
[95] S. Kent,et al. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection , 2021, medRxiv.
[96] M. Drayson,et al. Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection , 2021, Clinical and experimental immunology.
[97] A. Ducharme,et al. Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team , 2021, Canadian Journal of Cardiology.
[98] S. Scalvini,et al. Altered Vascular Endothelium-Dependent Responsiveness in Frail Elderly Patients Recovering from COVID-19 Pneumonia: Preliminary Evidence , 2021, Journal of clinical medicine.
[99] I. Al Busaidi,et al. Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man , 2021, Cureus.
[100] C. Giurgi-Oncu,et al. Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2 , 2021, Biology.
[101] N. Maskell,et al. Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series , 2021, Annals of Internal Medicine.
[102] S. Yong. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments , 2021, Infectious diseases.
[103] M. Spraul,et al. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome , 2021, Journal of proteome research.
[104] S. Rosenkranz,et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study , 2021, The Lancet Regional Health - Europe.
[105] F. Schuch,et al. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis , 2021, Frontiers in Immunology.
[106] Henrik Nielsen,et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study , 2021, The Lancet Infectious Diseases.
[107] N. Murillo,et al. What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. , 2021, NeuroRehabilitation.
[108] P. Kellman,et al. Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers , 2021, JACC: Cardiovascular Imaging.
[109] G. Wright,et al. Suspected subclinical myocarditis detected by cardiac magnetic resonance imaging late post COVID-19 recovery , 2021, Journal of Cardiology Cases.
[110] B. E. Fan,et al. ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. , 2021, Annals of the Academy of Medicine, Singapore.
[111] J. Courel-Ibáñez,et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise , 2021, International journal of environmental research and public health.
[112] J. Arano Llach,et al. Inappropriate sinus tachycardia in post-covid-19 Syndrome , 2021, Europace.
[113] F. Mentré,et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort , 2021, Clinical Microbiology and Infection.
[114] V. Marx. Scientists set out to connect the dots on long COVID , 2021, Nature Methods.
[115] M. L. La Rovere,et al. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors , 2021, medRxiv.
[116] S. Walker,et al. Patient symptoms and experience following COVID-19: results from a UK-wide survey , 2021, BMJ Open Respiratory Research.
[117] Manesh R. Patel,et al. SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes , 2021, Circulation.
[118] E. Benarroch,et al. Autonomic dysfunction following COVID-19 infection: an early experience , 2021, Clinical Autonomic Research.
[119] P. Ferdinandy,et al. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129 , 2021, Cardiovascular research.
[120] P. Nilsson,et al. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. , 2021, JAMA.
[121] M. Tobin-D'Angelo,et al. Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic. , 2021, JAMA pediatrics.
[122] Paul J. Harrison,et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records , 2021, The Lancet Psychiatry.
[123] B. Kostov,et al. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management , 2021, International journal of environmental research and public health.
[124] A. Banerjee,et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study , 2021, BMJ.
[125] R. Anderson,et al. The Leading Causes of Death in the US for 2020. , 2021, JAMA.
[126] K. Kraft,et al. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue , 2021, Nutrients.
[127] I. Torjesen. Covid-19: Middle aged women face greater risk of debilitating long term symptoms , 2021, BMJ.
[128] W. Lim,et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol , 2021, The Lancet Regional Health - Europe.
[129] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[130] M. Banach,et al. COVID-19 and cardiovascular complications – preliminary results of the LATE-COVID study , 2021, Archives of medical science : AMS.
[131] L. Cooper,et al. What we (don’t) know about myocardial injury after COVID-19 , 2021, European heart journal.
[132] David A. Drew,et al. Attributes and predictors of long COVID , 2021, Nature Medicine.
[133] C. Castilletti,et al. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression , 2021, Cardiovascular research.
[134] C. Bunker,et al. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy , 2021, The Lancet Infectious Diseases.
[135] M. Cecconi,et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[136] S. Villapol,et al. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis , 2021, Research square.
[137] D. Girelli,et al. Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 , 2021, Diagnostics.
[138] M. Ciccarelli,et al. Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art , 2021, Life.
[139] M. Brady,et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study , 2021, BMJ Open.
[140] Q. Ning,et al. Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. , 2021, The Journal of clinical investigation.
[141] R. Kumar,et al. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of 18F-FDG PET/CT to assess myocardial involvement , 2021, Journal of Nuclear Cardiology.
[142] S. Kesari,et al. A Review of Persistent Post-COVID Syndrome (PPCS) , 2021, Clinical Reviews in Allergy & Immunology.
[143] P. Kellman,et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance , 2021, European heart journal.
[144] G. Stefano. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID , 2021, Medical science monitor : international medical journal of experimental and clinical research.
[145] I. Martín-Loeches,et al. Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response , 2021, Journal of Thrombosis and Haemostasis.
[146] J. Guck,et al. Physical phenotype of blood cells is altered in COVID-19 , 2021, bioRxiv.
[147] A. Movila,et al. Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M–CSF– and IL-34-differentiated macrophages in vitro , 2021, Biochemical and Biophysical Research Communications.
[148] A. West,et al. Identifying patients at risk of post-discharge complications related to COVID-19 infection , 2021, Thorax.
[149] R. Steeds,et al. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study , 2021, Journal of the American Society of Echocardiography.
[150] L. Østergaard. SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation , 2021, Physiological reports.
[151] E. Wherry,et al. New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19 , 2021, medRxiv.
[152] John P. Moore,et al. SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants. , 2021, JAMA.
[153] M. Feltkamp,et al. Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach , 2021, EClinicalMedicine.
[154] Silamlak Birhanu Abegaz. Human ABO Blood Groups and Their Associations with Different Diseases , 2021, BioMed research international.
[155] C. Catena,et al. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge , 2021, Clinical Research in Cardiology.
[156] G. Erbaş,et al. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease , 2021, Scandinavian journal of clinical and laboratory investigation.
[157] W. Drygas,et al. Cardiac involvement in consecutive elite athletes recovered from Covid‐19: A magnetic resonance study , 2021, Journal of magnetic resonance imaging : JMRI.
[158] A. Bellasi,et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation , 2021, Epidemiology and Infection.
[159] S. Goldbarg,et al. Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19 , 2021, Journal of internal medicine.
[160] M. Andrés,et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study , 2021, Journal of Infection.
[161] M. Blasco,et al. Shorter telomere lengths in patients with severe COVID-19 disease , 2021, Aging.
[162] T. Welte,et al. Circulating cardiovascular microRNAs in critically ill COVID‐19 patients , 2021, European journal of heart failure.
[163] Asimina Dominari,et al. Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care , 2021, Journal of primary care & community health.
[164] Helio T. Navarro,et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia , 2020, Nature.
[165] A. Perotte,et al. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy , 2020, PloS one.
[166] T. Hobman,et al. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 , 2020, Viruses.
[167] J. Guevara-Coto,et al. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning , 2020, bioRxiv.
[168] F. Kronenberg,et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial , 2020, European Respiratory Journal.
[169] E. Sorbets,et al. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study , 2020, Journal of Infection.
[170] N. Mackman,et al. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[171] R. Sutton,et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. , 2020, Clinical medicine.
[172] E. Wood,et al. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.
[173] W. Heywood,et al. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. , 2020, F1000Research.
[174] L. Rénia,et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation , 2020, medRxiv.
[175] V. Chopra,et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 , 2020, Annals of Internal Medicine.
[176] S. Vasoo,et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients , 2020, Journal of Thrombosis and Thrombolysis.
[177] M. Nussenzweig,et al. Evolution of Antibody Immunity to SARS-CoV-2 , 2020, bioRxiv.
[178] M. Diamond,et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2020, bioRxiv.
[179] A. Alsheikh-Ali,et al. Molecular Basis of Cardiac and Vascular Injuries Associated With COVID-19 , 2020, Frontiers in Cardiovascular Medicine.
[180] Jeremy S. Brown,et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 , 2020, Thorax.
[181] A. Haberland,et al. Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins , 2020, Heliyon.
[182] M. Cecconi,et al. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[183] A. Cohen-Solal,et al. Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome , 2020, ESC heart failure.
[184] P. Laterre,et al. Short telomeres increase the risk of severe COVID-19 , 2020, Aging.
[185] K. Kurz,et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study , 2020, Respiratory Research.
[186] N. Marx,et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae , 2020, Respiratory Medicine.
[187] M. Jenkinson,et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge , 2020, EClinicalMedicine.
[188] K. Peter,et al. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities , 2020, Cardiovascular research.
[189] M. Honigsbaum,et al. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers , 2020, The Lancet.
[190] S. Kent,et al. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences , 2020, European Respiratory Journal.
[191] F. Bruyère,et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset , 2020, Clinical Microbiology and Infection.
[192] M. Spruit,et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? , 2020, ERJ Open Research.
[193] L. Hensley,et al. How NETosis could drive “Post-COVID-19 syndrome” among survivors , 2020, Immunology Letters.
[194] Haitham Saeed,et al. Assessment and characterisation of post‐COVID‐19 manifestations , 2020, International journal of clinical practice.
[195] M. H. Cheng,et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.
[196] Barbara B. Shih,et al. Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.
[197] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[198] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[199] Jiao Li,et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study , 2020, Clinical Microbiology and Infection.
[200] M. Borghesan,et al. Cellular senescence as a potential mediator of COVID‐19 severity in the elderly , 2020, Aging cell.
[201] L. Weinstock,et al. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome , 2020, International Journal of Infectious Diseases.
[202] W. Lim,et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study , 2020, medRxiv.
[203] K. Wilson,et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents , 2020, The Lancet Infectious Diseases.
[204] J. Mason,et al. A dynamic COVID-19 immune signature includes associations with poor prognosis , 2020, Nature Medicine.
[205] N. Maskell,et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. , 2020, medRxiv.
[206] T. Greenhalgh,et al. Management of post-acute covid-19 in primary care , 2020, BMJ.
[207] C. Weber,et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.
[208] Jay S. Steingrub,et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[209] Manoj Sivan,et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation , 2020, Journal of medical virology.
[210] J. Dowds,et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection , 2020, medRxiv.
[211] Eike Nagel,et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[212] P. Kirchhof,et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.
[213] Yanfeng Gao,et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery , 2020, EClinicalMedicine.
[214] Angelo Carfì,et al. Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.
[215] P. Buehler,et al. Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients , 2020, medRxiv.
[216] N. Narula,et al. Cardiology Practice and Training Post-COVID-19 , 2020, Journal of the American College of Cardiology.
[217] M. Dweck,et al. Global evaluation of echocardiography in patients with COVID-19 , 2020, European heart journal cardiovascular Imaging.
[218] J. Erdmann,et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.
[219] M. Blagosklonny. From causes of aging to death from COVID-19 , 2020, Aging.
[220] P. Davies,et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.
[221] A. Frangakis,et al. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes , 2020, bioRxiv.
[222] C. Page,et al. Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology , 2020, British journal of pharmacology.
[223] Hesong Zeng,et al. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging , 2020, JACC: Cardiovascular Imaging.
[224] V. Bansal,et al. A single-cell RNA expression map of human coronavirus entry factors , 2020, bioRxiv.
[225] M. Girardis,et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia , 2020, Nature Communications.
[226] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[227] Zhigang Tian,et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[228] Yong-tang Zheng,et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[229] Fenglian Ma,et al. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin , 2020, European heart journal.
[230] Qian Zhang. Human genetics of life-threatening influenza pneumonitis , 2020, Human Genetics.
[231] M. A. Said,et al. Genetically Determined ABO Blood Group and its Associations With Health and Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[232] Steve Horvath,et al. DNA methylation-based biomarkers and the epigenetic clock theory of ageing , 2018, Nature Reviews Genetics.
[233] Y. Li,et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection , 2017, Scientific Reports.
[234] Tobias Jung,et al. Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence , 2016, Redox biology.
[235] L. Cooper,et al. Imaging of Inflammation in Unexplained Cardiomyopathy. , 2016, JACC. Cardiovascular imaging.
[236] Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection , 2021 .